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Secretion of the proinflammatory cytokine IL-1b requires caspase-1 and Toll-like receptor (TLR)
signaling. However, Kanneganti et al. (2007) find that bacteria can use pore-forming mechanisms
to activate caspase-1 for the production of IL-1b precursor independently of TLRs.Several systemic and local inflamma-
tory diseases, including type 2 diabe-
tes, are due to the activity interleu-
kin-1b (IL-1b) (Larsen et al., 2007).
Although some of these inflammatory
diseases are due to mutations in the
nuclear oligomerization domain (NOD)-
like receptor (NLR) gene family mem-
ber cryopyrin (also known as CIAS-1
or NALP3), increased secretion of the
active cytokine rather than changes in
gene expression is fundamental to IL-
1b-mediated diseases. Indeed, an in-
crease in gene expression or synthesis
of the IL-1b precursor does not auto-
matically result in an increase in IL-1b
activity (Dinarello, 1996). Tight control
limits the processing of the inactive
IL-1b precursor and the secretion of
active IL-1b. The inactive IL-1b precur-
sor requires enzymatic cleavage into
an active cytokine by the intracellular
cysteine protease termed caspase-1.
Caspase-1 activation, however, is it-
self tightly controlled by the caspase-1
inflammasome, a complex of interact-
ing proteins associated with the pro-
tein cryopyrin (Martinon and Tschopp,
2007). Thus, cells deficient in cryopyrin
cannot activate caspase-1, and there
is no processing of the IL-1b precursor
in response to bacterial products via
the Toll-like receptors (TLRs). Mono-
cytes and macrophages from healthy
subjects and mice do not express
IL-1b but after stimulation by bacterial
products, rapidly synthesize the IL-1b
precursor. It is widely believed that
TLRs first activate IL-1b transcription
and translation and also initiate auto-
cleavage of inactive procaspase-1.
Once activated, caspase-1 then cuts
the IL-1b precursor, and mature IL-1b
is released from secretory lysosomesin the absence of cell death (Andrei
et al., 2004); alternatively, nonlysomal
release is associated with cell leak-
age and eventual death (Brough and
Rothwell, 2007).
TLRs, often lauded for their evolu-
tionary kinship with Drosophila genes,
are late in arriving at the junction of
bacterial-host interaction. Bacterial
products are prototypic examples of
activators of the so-called innate im-
mune system. Bacteria-host interac-
tions, however, predate any ‘‘immune’’
response by millions of years. Thus,
bacterial geneproducts canenter a cell
directly to mediate a host response,
and the best example is Anthrax,
where the lethal factor of Bacillus an-
thracis is transported by the protective
antigen into the host cytosol. Subse-
quently, this factor activates cas-
pase-1 through the NALP1b inflamma-
some (Boyden and Dietrich, 2006).
In this issue of Immunity, Kanneganti
et al. (2007) demonstrate the mecha-
nisms by which bacteria and bacterial
products can interact with the host cell
to activate caspase-1 independently
of TLRs. They demonstrate an unex-
pected mechanism of caspase-1 acti-
vation and IL-1b processing and se-
cretion; this mechanism is related to
a fundamental property of bacteria to
directly enter a host cell and has been
missed by the preoccupation with TLR
as the basis of innate immunity. Kan-
neganti et al. (2007) describe the ability
of bacteria and bacterial products to
directly enter the cell, bypassing any
function from TLRs but resulting in the
activation of caspase-1. The studies
are convincing in that TLR4 is shown
to be completely nonessential for rou-
tine bacteria to activate caspase-1.ImmunThe study also shows that heat-killed
bacteria are delivered into the cytosol
through a mechanism involving the
hemichannel pannexin-1. The cyto-
solic presence of bacterial molecules
triggers the activation of the cryopyrin
inflammasome and the conversion of
inactive procaspase-1 to active cas-
psase-1. Thus, the pannexin-1 pore
appears to provide a pathway resulting
in active IL-1b. Each of these steps
takes place without any participation
by TLR, although TLR signaling is re-
quired for transcription of the IL-1b
precursor. Although the pannexin-1
channels have been studied for their
ability to provide large pores for dyes
to enter the cells, the trafficking of
dyes can hardly be considered the pri-
mary function of pannexin-1. Indeed,
an earlier report (Pelegrin and Surpren-
ant, 2007) demonstrate that pannexin-1
is required for caspase-1 activation
and secretion of IL-1b after activation
of the purinergic receptor P2X7 by ATP
and the efflux of potassium ions.
It remains unclear how the entering
bacteria or bacterial products activate
the inflammasome, but the endosomal
functions are clearly required. We are
reminded that muramyl dipeptide
(MDP), the basic biologically active
product of peptidoglycans present in
all bacteria, has no cell-surface TLR.
Rather, it directly enters the cell to be
recognized by its intracellular recep-
tor, NOD2, thus resulting in gene ex-
pression, synthesis, and processing
and secretion of active IL-1b. Does
MDP also employ pannexin-1 and
endosomal function to activate the in-
flammasome? Kanneganti et al. (2007)
provide evidence that the pannexin-1
and cryopyrin mediate MDP-inducedity 26, April 2007 ª2007 Elsevier Inc. 383
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PreviewsFigure 1. Multiple Signals Are Needed for the Secretion of Active IL-1b
TLR ligands via the Toll-IL-1 receptor (TIR) initiate the transcription and translation of IL-1b (signal 1
and signal 2). The pannexin-1 channel facilitates the entry of bacteria and bacterial products into
the cell via endosomes (signal 3). Although themechanism is unclear at present, bacteria and bac-
terial products, independently of TLR, activate caspase-1 after the association of procaspase-1
with cryopyrin through the adaptor molecule ASC in the inflammasome. Activation of caspase-1
may be initiated by the recognition of bacterial products to the leucine-rich repeats (LRR) of cry-
opyrin (signal 4). Signal 5 begins with ATP activation of the P2X7 receptor and the rapid exit of po-
tassium from the cell. The efflux of potassium may take place via the potassium channel (signal 6)
or P2X7 (signal 5). The IL-1b precursor and caspase-1 are found in the secretory lysosome (Andrei
et al., 2004). After ATP activation of the P2X7 receptor, rapid exit of potassium is a trigger for the
cleavage of the IL-1b precursor whether from the secretory lysosome (Andrei et al., 2004) or pos-
sibly from the cytosol (Brough andRothwell, 2007). A rise in intracellular calcium is also required for
the secretion of processed IL-1b (signal 7).caspase-1 activation. In this model,
NOD2 induces IL-1b transcription
via the NF-kB transcription factor,
whereas cryopyrinmediates caspase-1
activation and IL-1b processing. It is
also possible that MDP triggers cas-
pase-1 activation through both NOD2
and cryopyrin pathways. Figure 1 illus-
trates the multiple signals that partici-
pate in the secretion of active IL-1b.
As shown, bacterial products such as
MDP enter the cell facilitated by pan-
nexin-1 (signal 3) and bind to the leu-
cine-rich repeats (LRR) of cryopyrin.
Although this is an attractive hypo-
thesis based on the similarities of the
pathogen-associated microbial pat-
terns of the extracellular domains of
TLR, it remains speculative whether
MDP actually binds to the LRR or acti-
vates the inflammasome by another
mechanism.
If the fundamental bacterial interac-
tion is to damage the host or produce384 Immunity 26, April 2007 ª2007 Elseva harmful inflammatory response, then
the host must set up a series of road-
blocks and requirements to fend off the
harmful intention of the invader. Unlike
TNFa or IL-6, IL-1b has a remarkable
set of roadblocks and requirements
before an active cytokine is secreted
to trigger its nearby or distant recep-
tors. First, there is the requirement to
transcribe the IL-1b gene and translate
the transcript into the inactive precur-
sor. This step itself does not proceed
as expected. Indeed, one can have
large amount of polyadenylatedmRNA
for IL-1b without substantial transla-
tion. For example, the proinflamma-
tory complement C5a stimulates a
large amount of IL-1b mRNA that re-
quires a second signal for translation.
The second signal for translation can
be a TLR ligand or IL-1b itself. Given
the fact that TLR4 is not needed for
caspase-1 activation by LPS, the func-
tion of TLR4 now is demoted to provid-ier Inc.ing transcriptional and translational
signal. The essential role of activation
of cryopyrin for IL-1b processing can
use the pannexin-1 pathway without
any help from TLR4. In addition, the re-
port also shows that the adaptor pro-
tein ASC is needed for a functional
inflammasome to activate caspase-1
downstream of the pannexin-1 path-
way. Some readers will maintain that
secretion of IL-1b is a host-defense
mechanism by which IL-1b provides
the host with a modicum of protection.
But there is no dearth of evidence that
anymechanism that results in a greater
secretion of IL-1b is, in fact, detrimen-
tal to the host by the proinflammatory
properties of IL-1b. Increased IL-1b
production may benefit the lizard or
the fruit fly for survival, but this is hardly
the situation in mammals.
What is missing? The pannexin-1
channel is an example of how micro-
organisms or their products are de-
termined to enter the cell and to not
depend upon a single mechanism. In
the case of the TLR4, we are left with
the conundrum that the receptor is
needed for induced transcription of
IL-1b (as well as several other cyto-
kines) but little else when one con-
siders the ability of bacterial products
to activate caspase-1 independently
of TLR. Whereas the Kanenganti et al.
findings broaden the mechanisms by
which bacteria-host interactions take
place in the activation of the inflamma-
some, bacterial products do not ac-
count for the inflammatory diseases
that are mediated by an increased
IL-1b secretion. IL-1b induction of
itself is perhaps a major mechanism
for several inflammatory diseases.
Indeed, we need to know if cytokines
themselves can bypass their own
receptors and use channels and en-
dosomes to enter the cell directly and
activate caspase-1 or gene expres-
sion. Certainly, the paucity of IL-1 re-
ceptors on cells responsive to picomo-
lar concentrations of IL-1 suggests
that alternate mechanisms exist for
IL-1 to activate the cell.
What else is missing? The vast
majority of investigators studying the
secretion of IL-1b from primary mono-
cytes, macrophages, or cell lines
incubate these cells with endotoxins
from Gram-negative bacteria, various
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MDP, or other agents recognized as
pathogen-associated molecular pat-
terns for 24 hr, during which time there
is a steady increase in the synthesis of
the IL-1b precursor. Most of the IL-1b
precursor remains in the cytosol, but
approximately 20% is slowly secreted
into the supernatant after cleavage by
caspase-1. Investigators studying the
inflammasome accelerate the cleav-
age of the IL-1b precursor by shocking
the cell with millimolar concentrations
of ATP. Within 15–20 min, processed
IL-1b is secreted. Whether it occurs
slowly overnight or in a matter of min-
utes, activation of caspase-1 by the
inflammasone is essential. Indeed, in
primary monocytes from patients with
the juvenile form of Still’s disease
(Pascual et al., 2005) or neonatal onset
multi-inflammatory disease (Goldbach-
Mansky et al., 2006) secrete signifi-
cantly more IL-1b whether in a resting
state or after endotoxin stimulation
during a 24 hr culture without the addi-
tion of ATP. Although from neutrophils
there are natural products that trigger
the P2X7 receptor and although ATP
can accumulate in the extracellularReady for Prime
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Natural killer (NK) cells were long
issue of Immunity, Lucas et al. (2
through priming by dendritic cell
Introductory statements often de-
scribe natural killer (NK) cells as a ‘‘first
line of defense’’ against infections and
tumor cells and as potent effector cells
that secrete cytokines and kill target
cells to provide a rapid response
‘‘without the need for priming.’’ Recent
work has revealed a more complexspace at sites of inflammation, the role
of pannexin-1 in the absence of the
ATP ‘‘quick fix’’ needs to be estab-
lished in primary human monocytes.
In contrast to the findings of pan-
nexin-1-mediated activation of the in-
flammasome, one must consider that
obligate intracellular micro-organisms
such as Mycobacteria and Leishmania
are not interested in inducing much of
an inflammatory responseuntil theyare
ready to leave their host cell in much
larger numbers in order to spread
the infection. By isolating themselves
intracellularly, these microorganisms
avoid activating caspase-1. In support
of this, the Kanneganti et al. (2007)
study shows that upon entering the
cell, the stability of the endosome de-
termines the activation of caspase-1.
Chloroquine and other anti-malarials
are well-established therapeutics in
treating autoimmune diseases. Chlo-
roquine stabilized the endosome and
reduced caspase-1 activation by killed
bacteria. Therefore, the study by Kan-
neganti et al. (2007) also explains the
mechanism by which anti-malarials,
used to treat autoimmune diseases,
affects cytokine production.Time:
by Dendritic Cells
H, 12441 Parklawn Drive, Rockville, MD 208
thought to respond directly to infe
007) repeal this view by showing t
s.
picture in which NK cells are an inte-
gral part of the immune system, receiv-
ing signals that regulate their activity
and, in turn, providing signals that
shape adaptive immune responses.
Important functional interactions be-
tween dendritic cells (DCs) and NK
cells result in their mutual regulation
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